PROTOCOL

soumyapottola 710 views 20 slides Mar 30, 2024
Slide 1
Slide 1 of 20
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20

About This Presentation

Definition. A clinical research protocol is a document that describes the background, rationale, objectives, design, enrollment criteria, methodology, data recording requirements, statistical considerations, and organization of a clinical research study.
Here's a list of steps on how to write a ...


Slide Content

PROTOCOL [email protected] | https://clinicalda.blogspot.com

contents Study title Signature page Content page Objectives Introduction Study design and rationale Inclusion and Exclusion criteria Safety/Adverse events Schema Schedule of assessment table List of abbreviation and Definition of terms

Study title Definition : A research protocol is written to detail a clinical study plan to meet specified ethical norms for participating subjects . It is a plan to obtain funding or conduct research. It is meant to clearly provide an overview of a proposed study to satisfy an organization's guidelines for protecting the safety of subjects.

Who reads protocol The protocol language/content should be understood by Principal investigator Nurses/CRAs Clinical data management team members S cientific reviewers Clinical operators IRB members

Title page The title page introduce the document,its title,precise number, sponsor and author to the reader. Protocol identifying number and date. Any amendment should also bear the amendment number and date. The protocol number must clearly indicate the version number,whether it is final or draft and date of the version.

Title page includes: Title pages introduce the document, their title, precise number, sponsor and author to the reader Protocol title, protocol identifying number, and date Any amendments should also bear the amendment number and date The protocol number must clearly indicate the version number, whether it is final or draft and date of this version

Elements full title should include : Placebo Summary study design Indication Patient population Medicinal products Setting (ex: in-patient, outpatient) Nature of the treatment (ex: treatment, prophylaxis and diagnosis) Randomized Double Blind Multiple Studies Comparator

Title page includes Name and address of the sponsor and monitor. Sponsor names and list of responsibilities with agreed allocations Name and title of the person authorized to sign the protocol and the protocol amendments for the sponsor. Generally, Chief Investigator for multiple center trials or Principal Investigator for single center trials Name, title, address and telephone number of the sponsor medical expert for the trial Name and title of the investigator who is responsible for conducting the trial, and the address and telephone numbers of the trial site Name, title , address and telephone number of the qualified physician who is responsible for all trial site related medical decisions Name and address of the clinical laboratory and other medical and /or technical department and /or institution involved in the trial

Protocol summary/synopsis A clinical trial often has both primary and secondary objective, and these should be identified as such in the protocol Ideally, no more than 1 or 2 of each should be included in a clinical trial 2. Signature page Signature page of the healthcare professional in the trial including contact details of participating site, sponsor and sponsor medical advisor if not already given above.

3.Content page This helps navigating through the document by large number of different people that will be needed throughout the life of the trial. 4.Study objectives/arms A clinical trial often has both primary and secondary objective, and these should be identified as such in the protocol Ideally, no more than 1 or 2 of each should be included in a clinical trial

5.Introduction A research protocol is written to detail a clinical study's plan to meet specified ethical norms for participating subjects . It is a plan to obtain funding or conduct research. It is meant to clearly provide an overview of a proposed study to satisfy an organization's guidelines for protecting the safety of subjects.

6.Study design and rationale A description of the design of trial to be conducted ex: double blind, placebo controlled, parallel design 2) A description of the measure taken to minimize/ avoid bias A) Randomization B) Blinding and dosage regimen of the IP. Also, include a description of the dosage form, packaging and labeling of the IP 4) The expected duration of subject participation,and description of the sequence and duration of all trial periods, including follow up any. 5) A description of “stopping rile” or “Discontinuation Criteria”

7.Inclusion and exclusion criteria What are inclusion criteria? Inclusion criteria comprise the characteristics or attributes that prospective research participants must have in order to be included in the study. Common inclusion criteria can be demographic, clinical, or geographic in nature. Example: Inclusion criteria You are running a clinical trial for a new treatment for individuals with chronic heart failure. The following inclusion criteria apply: 18 to 80 years of age Diagnosis of chronic heart failure at least 6 months before trial On stable doses of heart failure therapies Willing to return for required follow-up (posttest) visits People who meet the inclusion criteria are then eligible to participate in the study.

Exclusion criteria What are exclusion criteria? Exclusion criteria comprise characteristics used to identify potential research participants who should not be included in a study. These can also include those that lead to participants withdrawing from a research study after being initially included. In other words, individuals who meet the inclusion criteria may also possess additional characteristics that can interfere with the outcome Ethical considerations , such as be of the study. For this reason, they must be excluded. Typical exclusion criteria can be: ing a minor or being unable to give informed consent Practical considerations, such as not being able to read

continues…….. If potential participants possess any additional characteristics that can affect the results, such as another medical condition or a pregnancy, these are also often grounds for exclusion. Example: Exclusion criteria In the clinical trial for individuals with chronic heart failure, the following exclusion criteria apply: The patient requires valve or other cardiac surgery The patient is unable to carry out any physical activity without discomfort The patient had a stroke within three months prior to enrollment The patient refuses to give informed consent The patient is a candidate for coronary bypass surgery or something similar People who meet one or more of the exclusion criteria must be disqualified. This means that they can’t participate in the study even if they meet the inclusion criteria.

8.Safety/Adverse Effects The methods and timing for assessing, recording, and analyzing safety parameters Procedure for eliciting reports of and recording and reporting adverse event and intercurrent illnesses. Safety parameters will include the incidence of AEs, SAEs, treatment discontinuations or dose interruptions or dose reductions due to AEs, AECIs, changes in ECOG performance status, changes in clinical laboratory results (hematology, chemistry, and urinalysis),vital sign measurements, observations during physical examination, and use of concomitant medications.

9.Schema Overall Study Design EXAMPLE:

10.Schedule of assessments The Schedule of Activities (SoA) forms a key part of a Clinical Trial Protocol; it is usually presented as a table with the columns detailing planned study 'visits' (Encounters) and the rows the details of study activities (Activities) that are to be undertaken at that visit, and they are key to understanding how the ..

11.List of abbreviations and define of terms Abbreviations are shortened forms of words and phrases and are a common occurrence in research manuscripts as they can help make highly complex technical writing more concise and easier to read.

CONCLUSION Protocol is a blueprint for a study. It contains all the information necessary Certain Information is required by regulation to be into protocol The following are the key points that follow Data Management Protocol: Data Recording GCDMP DMP Data Capture CRF Practices Quality Assurance Data Validation Query Management Statistical Analysis Data Locking